Muutke küpsiste eelistusi

Cancer Immunosurveillance: Methods and Protocols Second Edition 2025 [Kõva köide]

  • Formaat: Hardback, 308 pages, kõrgus x laius: 254x178 mm, 48 Illustrations, color; 8 Illustrations, black and white; XIII, 308 p. 56 illus., 48 illus. in color., 1 Hardback
  • Sari: Methods in Molecular Biology 2930
  • Ilmumisaeg: 23-May-2025
  • Kirjastus: Springer-Verlag New York Inc.
  • ISBN-10: 1071645579
  • ISBN-13: 9781071645574
Teised raamatud teemal:
  • Kõva köide
  • Hind: 169,14 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 198,99 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 308 pages, kõrgus x laius: 254x178 mm, 48 Illustrations, color; 8 Illustrations, black and white; XIII, 308 p. 56 illus., 48 illus. in color., 1 Hardback
  • Sari: Methods in Molecular Biology 2930
  • Ilmumisaeg: 23-May-2025
  • Kirjastus: Springer-Verlag New York Inc.
  • ISBN-10: 1071645579
  • ISBN-13: 9781071645574
Teised raamatud teemal:

This new edition explores the innovation and improvement of experimental techniques harnessed to dissect the complex relationship between cancer cells and the immune system of the host. Beginning with spectral and multicolor flow cytometric methods to characterize the immune contexture of different forms of metastases, the book continues with functional assays to study the activation status of immune cells with antitumor properties, bioinformatic approaches of interest for cancer immunology research, techniques for performing epigenetic studies, as well as methods related to translational research. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step and readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

 

Authoritative and up-to-date, Cancer Immunosurveillance: Methods and Protocols, Second Edition serves as a valuable resource for scientists seeking inspiration for new ideas and research in the field of tumor immunology.

Characterization of Bone Marrow-Derived Immune Compartment in Murine
Brain Metastases by Spectral Flow Cytometry.- Multicolor Flow Cytometry for
Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis
Mice Models.- Application of Cellular Indexing of Transcriptomes and Epitopes
by Sequencing (CITE-Seq) to Precisely Dissect the Brain Tumor Immune
Microenvironment.- Magnetic Bead Based Isolation of CD8+ T Cells from the
Mouse Spleen.- Phosphoflow: Evaluation of Protein Phosphorylation Status by
Cytofluorimetric Assay.- Evaluation of NF-kB Nuclear Translocation in Natural
Killer Cells by Imaging Multispectral Flow Cytometry as a Marker of
Anticancer Immune Activation.- A Colony Formation-Based Assay to Evaluate
Natural Killer Cell Antitumor Responses In Vitro.- NKT Hybridoma Cell
Stimulation Assays to Evaluate Glycolipid Specificity and Processing.-
Metabolic Profiling of Tumor and Immune Cells Integrating Seahorse and Flow
Cytometry.- Kinetic Assessment of HMGB1 Exodus by Automated Live Cell
Imaging.- The Immunogenic Tumor Specific Neoantigen Database (ITSNdb): A Tool
for Comprehensive Performance Evaluation of Neoantigen Immunogenicity
Predictors.- A Robust Quantitative Multiplex PCR for T-Cell Receptor
Repertoire Sequencing from Formalin-Fixed Paraffin-Embedded Samples.- Immune
Single-Cell Annotation by Molecular Signature-Based Deconvolution with
MIXTURE.- Chromatin Preparation from Frozen Tissues for Chromatin
Immunoprecipitation (ChIP) Assays.- Exploring the Cancer Immune Epigenome by
ATAC-Seq.- Epigenomic Profiling of Histone Post-Translational Modifications
in Frozen Cancer Tissue Using CUT&RUN.- A Luminescence-Based Method for In
Vitro Screening of Immunomodulatory Checkpoints and Therapeutics.- Generation
of Human Monocyte-Derived Immunogenic Dendritic Cells via mTORC1 and PPAR
Inhibition.- Engineered CAR-NK Cells for Cancer Immunotherapy:
Lentiviral-Based CAR Transduction of NK-92 Cells.- Optimal Structural Designs
of Trispecific Antibodies to Enhance Therapeutic Efficacy in Solid Tumors and
Hematological Malignancies.- Microbiota Transplantation in Tumor Immunology
Studies.